Zahra Sabourinejad

Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells.

F. Esmaeili, M. Momeny, Hassan Yousefi, 2020, European journal of pharmacology.

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer

F. Esmaeili, M. Momeny, Ghazaleh Zarrinrad, 2018, Tumori.

Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.

F. Esmaeili, M. Momeny, Ghazaleh Zarrinrad, 2018, The international journal of biochemistry & cell biology.

Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells

M. Momeny, Ghazaleh Zarrinrad, K. Alimoghaddam, 2017, Scientific Reports.

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

M. Momeny, Ghazaleh Zarrinrad, M. Yaghmaie, 2017, Scientific Reports.

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

F. Esmaeili, M. Momeny, R. Ghasemi, 2017, Scientific Reports.

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

F. Esmaeili, M. Momeny, R. Ghasemi, 2017, Scientific Reports.